These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16983394)
1. Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields. Jani AB; Su A; Correa D; Gratzle J Prostate Cancer Prostatic Dis; 2007; 10(1):82-6. PubMed ID: 16983394 [TBL] [Abstract][Full Text] [Related]
2. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807 [TBL] [Abstract][Full Text] [Related]
3. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725 [TBL] [Abstract][Full Text] [Related]
4. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587 [TBL] [Abstract][Full Text] [Related]
5. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526 [TBL] [Abstract][Full Text] [Related]
6. Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique. Su AW; Jani AB Am J Clin Oncol; 2007 Jun; 30(3):215-9. PubMed ID: 17551295 [TBL] [Abstract][Full Text] [Related]
7. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Nath SK; Sandhu AP; Rose BS; Simpson DR; Nobiensky PD; Wang JZ; Millard F; Kane CJ; Parsons JK; Mundt AJ Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):435-41. PubMed ID: 19939580 [TBL] [Abstract][Full Text] [Related]
8. Influence of intensity-modulated radiotherapy on acute genitourinary and gastrointestinal toxicity in the treatment of localized prostate cancer. Jani AB; Gratzle J; Correa D Technol Cancer Res Treat; 2007 Feb; 6(1):11-5. PubMed ID: 17241095 [TBL] [Abstract][Full Text] [Related]
9. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy. Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069 [TBL] [Abstract][Full Text] [Related]
10. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Jani AB; Parikh SD; Vijayakumar S; Gratzle J Urology; 2005 Jun; 65(6):1157-62. PubMed ID: 15913725 [TBL] [Abstract][Full Text] [Related]
11. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Cahlon O; Zelefsky MJ; Shippy A; Chan H; Fuks Z; Yamada Y; Hunt M; Greenstein S; Amols H Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):330-7. PubMed ID: 18164858 [TBL] [Abstract][Full Text] [Related]
12. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer. Cheng JC; Schultheiss TE; Nguyen KH; Wong JY Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841 [TBL] [Abstract][Full Text] [Related]
13. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy. Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939 [TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity. Jani AB; Su A; Milano MT Urology; 2006 Jan; 67(1):147-51. PubMed ID: 16413351 [TBL] [Abstract][Full Text] [Related]
15. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus. Kalakota K; Liauw SL Urology; 2013 Jun; 81(6):1196-201. PubMed ID: 23540863 [TBL] [Abstract][Full Text] [Related]
17. Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity? Chen MJ; Weltman E; Hanriot RM; Luz FP; Cecílio PJ; da Cruz JC; Moreira FR; Santos AS; Martins LC; Nadalin W Radiat Oncol; 2007 Jan; 2():6. PubMed ID: 17224072 [TBL] [Abstract][Full Text] [Related]
18. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Fonteyne V; Villeirs G; Lumen N; De Meerleer G Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817 [TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Sharma NK; Li T; Chen DY; Pollack A; Horwitz EM; Buyyounouski MK Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):437-44. PubMed ID: 21050673 [TBL] [Abstract][Full Text] [Related]
20. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]